Quest Diagnostics (NYSE:DGX) has been on a positive run, with several key financial firms upgrading its outlook. The firm is in the news for launching its health coaching platform via questhealth.com, aiding individuals to manage their wellness adeptly. The firm also joined forces with
Mainz Biomed and has advanced its green initiative, reducing CO2 emissions via renewable energy use. The company declared a quarterly cash dividend and shared their strategic moves at the 7th Annual Evercore HealthCONx Conference, thereby enriching their financial perspective.
Quest Diagnostics acquired
LifeLabs, increased their diagnostic services, and furthered its hold in the digital health sector. The firm's stock performed admirably, making prominent gains from new product offerings and customer acquisitions. The company's third quarter 2024 financial results met analysts' expectations, with earnings and revenues beating estimates.
In an impressive move,
BD collaborated with Quest Diagnostics to develop companion diagnostics for cancer and other diseases. On the sustainability front, the firm significantly enhanced its cybersecurity framework to protect patient data and increased transparency through the release of the corporate responsibility report.
Quest Diagnostics DGX News Analytics from Tue, 02 Apr 2024 07:00:00 GMT to Sat, 21 Dec 2024 04:41:44 GMT -
Rating 8
- Innovation 7
- Information 6
- Rumor 2
